Home
Integrated Core Strategies reported a 4.1% stake in Enanta Pharmaceuticals ENTA · 1,138,484 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.1%
- Last report
- 6.5% · filed 25/01/22
- Shares held
- 1,138,484 sh
- Class
- Common Stock, par value $0.01 per share
- Event date
- 25/09/30
- Filed
- 25/11/13
4.1% stake · below 5%
- Stake
- 4.1%
- Last report
- 6.5%
- Since last report
- −2.4pp
Enanta Pharmaceuticals trades, last 26 weeks
What else happened in Enanta Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 25/08/31~25/10/30Integrated Core Strategies's other 5% stake reports
- Integrated Core Strategies
5% stakeBetter Home & Finance Holding
5% stakeBetter Home & Finance Holding
BETR
5.5% stake
730,265 sh
5.5% stake
Filed 09/22
- Integrated Core Strategies
5% stakeKaryopharm Therapeutics
5% stakeKaryopharm Therapeutics
KPTI
5.7% stake
1,297,297 sh
5.7% stake
Filed 09/04
- Integrated Core Strategies
5% stakeFortress Biotech
5% stakeFortress Biotech
FBIO
5.3% stake
1,778,561 sh
5.3% stake
Filed 09/01
- Integrated Core Strategies
5% stakeTenaya Therapeutics
5% stakeTenaya Therapeutics
TNYA
5.2% stake
11,581,565 sh
5.2% stake
Filed 08/24
- Integrated Core Strategies
5% stakeCollegium Pharmaceutical
5% stakeCollegium Pharmaceutical
COLL
5.6% stake
1,820,330 sh
5.6% stake
Filed 08/24
